Press Release5 Minute ReadMar | 28 | 2022
Immune cells produce chemical messenger that prevents heart disease–related inflammation
- In the bone marrow, B cells produce a chemical messenger called acetylcholine that prevents inflammation in the heart and blood vessels by blocking white blood cell production.
- Tapping into this process may help scientists target inflammation in cardiovascular conditions.
Matthias Nahrendorf, MD, PhD
Ultimately this may lead to new therapeutics that combat myocardial infarction, stroke, and heart failure.
Center for Systems Biology, Massachusetts General Hospital
BOSTON – The immune system’s white blood cells, which are produced in the bone marrow, mostly help to defend against bacteria and injury, but sometimes they can turn against the body—for example, in cardiovascular disease, their inflammatory aggression can harm arteries and the heart. New research in Nature Immunology that was led by investigators at Massachusetts General Hospital (MGH) provides insights into the pathways that increase or decrease the bone marrow’s output of these cells. The findings may lead to new treatments for conditions that arise when the balance of white blood cell production goes awry.
Senior author Matthias Nahrendorf, MD, PhD, an investigator in MGH’s Center for Systems Biology and The Richard Moerschner professor at the MGH Research Institute and Harvard Medical School, explains that the nervous system plays a role in controlling blood cell production through chemical messengers or neurotransmitters. “This is for instance important in people exposed to stress, where stress hormones—part of the ‘fight-or-flight’ response controlled by the sympathetic nervous system—may increase bone marrow activity and cardiovascular inflammation in response to the neurotransmitter noradrenaline,” he says. The sympathetic nerves have a counter player—the parasympathetic nerves, which slow down responses and bring about a state of calm to the body, mainly through the neurotransmitter acetylcholine.
Because acetylcholine can have a protective effect against inflammation and heart disease, the researchers studied this neurotransmitter in the bone marrow. “When we looked into how acetylcholine acts on the production of blood cells, we found that it does the expected—it reduces white blood cells, as opposed to noradrenaline, which increases them,” says Nahrendorf. “What was unexpected though was the source of the neurotransmitter acetylcholine.”
The team found no evidence in the bone marrow of the typical nerve fibers that are known to release acetylcholine. Instead, B cells, which are themselves a type of white blood cell (most known for making antibodies), supplied the acetylcholine in the bone marrow. “Thus, B cells counter inflammation—even in the heart and the arteries—via dampening white blood cell production in the bone marrow. Surprisingly, they use a neurotransmitter to do so,” says Nahrendorf.
Tapping into this process may help investigators develop strategies to block inflammation in cardiovascular conditions such as atherosclerosis. “Ultimately this may lead to new therapeutics that combat myocardial infarction, stroke, and heart failure,” says Nahrendorf.
Additional study authors include Maximilian J. Schloss, Maarten Hulsmans, David Rohde, I-Hsiu Lee, Nicolas Severe, Brody H. Foy, Fadi E. Pulous, Shuang Zhang, Konstantinos D. Kokkaliaris, Vanessa Frodermann, Gabriel Courties, Chongbo Yang, Yoshiko Iwamoto, Anders Steen Knudsen, Cameron S. McAlpine, Masahiro Yamazoe, Stephen P. Schmidt, Gregory R. Wojtkiewicz, Gustavo Santos Masson, Karin Gustafsson, Diane Capen, Dennis Brown, John M. Higgins, David T. Scadden, Peter Libby, Filip K. Swirski, and Kamila Naxerova.
This work was supported in part by the National Heart Lung and Blood Institute at the National Institutes of Health (grant HL142494) and the MGH Research Scholar program.
About the Massachusetts General Hospital
Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The Mass General Research Institute conducts the largest hospital-based research program in the nation, with annual research operations of more than $1 billion and comprises more than 9,500 researchers working across more than 30 institutes, centers and departments. In August 2021, Mass General was named #5 in the U.S. News & World Report list of "America’s Best Hospitals." MGH is a founding member of the Mass General Brigham health care system.